Blog - Page 17 | NB Medical
 

Blog - Page 17

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE

Cognitive bias and the importance of safety netting

Cognitive bias and the importance of safety netting  image
Dr Rob Walker
17th November 2022

Safety netting is something that is drummed into us at a very early stage in our medical careers. It’s a recommended part of a standard consultation, and one that we all got taught to do as GP trainees,...

Sitting (or not), stepping, sweating, strengthening and sleeping – the five S’s approach to managing Type 2 Diabetes

Sitting (or not), stepping, sweating, strengthening and sleeping – the five S’s approach to managing Type 2 Diabetes  image
Dr Sarah Davies
10th November 2022

Earlier in 2022 we had a update to the NICE Type 2 diabetes guidelines with significant changes around prescribing, especially first line medications with an emphasis on using metformin and SGLT2 inhibitors...

Overprescribing, functional dyspepsia and PPWhy’s?

Overprescribing, functional dyspepsia and PPWhy’s?  image
Dr Rachel Brettell
3rd November 2022

Sometimes (often), it feels like us GP's can't do anything right.

Gout: Mind the (evidence) Gap

Gout: Mind the (evidence) Gap image
Dr Rob Walker
20th October 2022

Guidelines. Love ‘em or hate ‘em, we know they are an important tool to help us manage the massive range of problems we see in General Practice. As GPs we can’t know the ins and outs of the evidence base...

Rotator Cuff Related Shoulder Pain - New name, new evidence?

Rotator Cuff Related Shoulder Pain - New name, new evidence?  image
Dr Rob Walker
13th October 2022

Bob has just turned 47, and by his own admission is an impatient man. He is getting some pain again in his shoulder which is affecting his weekend games of tennis, so has booked to see you so he can get...

SGLT2 inhibitors for Heart failure with preserved ejection fraction

SGLT2 inhibitors for Heart failure with preserved ejection fraction   image
Dr Nick Jones
6th October 2022

The rise and rise of the SGLT2 inhibitors over the past few years has been so jaw-dropping that a recent editorial in the European Heart Journal even compared their development to that of ‘aspirin, penicillin,...